Funding · Commerce & Consumer Brands

Wingreens raises ₹120 cr in series d funding

What they do

Wingreens makes healthy snacks, juices, and dairy-free drinks under brands like Raw Pressery

The company raised ₹120 crore led by Ashish Kacholia to expand products and distribution networks

It also acquired Safe Harvest to integrate farm-to-consumer supply chains and targets an IPO soon

Wingreens Farms concluded its Series D funding round raising ₹120 Cr ($12.6 Mn).
Ashish Kacholia served as the lead investor for this latest funding round.
Alchemy Fund participated as an investor alongside the lead in this transaction.
The company simultaneously executed an acquisition of Safe Harvest through a share swap deal.
This strategic move aims to build an integrated farm-to-consumer platform for better supply chain control.
Wingreens plans to use the funds for product expansion, distribution growth, and innovation.
The firm has achieved EBITDA profitability for the fiscal year FY26.
Management targets a public listing (IPO) within the next two years.
Total capital raised to date now stands at $76.5 Mn across all rounds.

Consumer shift towards healthy snacking is driving significant investor interest in this sector.
Wingreens competes with peers like Wonderland Foods and The Whole Truth who have raised large sums.
The acquisition of Safe Harvest strengthens its position in the pesticide-free staples market.

Wingreens manufactures healthy snacks, sauces, dips, and breakfast cereals.
It produces non-dairy milk and protein shakes for health-conscious consumers.
The brand Raw Pressery sells FMCG cold-pressed juices and beverages.
Wingreens aims to integrate farmer partnerships into its core supply chain operations.

Wingreens plans to list publicly via an IPO within the next two years.
The company will focus on supply chain integration and farmer partnerships.
It intends to expand its distribution network and product portfolio.